Deakin University
Browse

Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study

Version 2 2024-06-04, 12:35
Version 1 2018-10-01, 00:00
journal contribution
posted on 2024-06-04, 12:35 authored by Clara K Chow, Chinthanie Ramasundarahettige, Weihong Hu, Khalid F AlHabib, Alvaro Avezum, Xiaoru Cheng, Jephat Chifamba, Gilles Dagenais, Antonio Dans, Bonaventure A Egbujie, Rajeev Gupta, Romaina Iqbal, Noorhassim Ismail, Mirac V Keskinler, Rasha Khatib, Lanthe Kruger, Rajesh Kumar, Fernando Lanas, Scott Lear, Patricio Lopez-Jaramillo, Martin McKee, Noushin Mohammadifard, Viswanathan Mohan, Prem Mony, Andres Orlandini, Annika Rosengren, Krishnapillai Vijayakumar, Li Wei, Karen Yeates, Khalid Yusoff, Rita Yusuf, Afzalhussein Yusufali, Katarzyna Zatonska, Yihong Zhou, Shariful Islam, Daniel Corsi, Sumathy Rangarajan, Koon Teo, Hertzel C Gerstein, Salim Yusuf
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study

History

Related Materials

Location

England

Language

English

Publication classification

C1 Refereed article in a scholarly journal

Copyright notice

2018, Elsevier Ltd.

Journal

LANCET DIABETES & ENDOCRINOLOGY

Volume

6

Pagination

798-808

ISSN

2213-8587

eISSN

2213-8595

Issue

10

Publisher

ELSEVIER SCIENCE INC